NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 11 04:00PM ET
1.05
Dollar change
-0.04
Percentage change
-3.67
%
Index- P/E- EPS (ttm)-12.81 Insider Own14.49% Shs Outstand2.50M Perf Week6.06%
Market Cap2.62M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.14M Perf Month-16.67%
Enterprise Value2.14M PEG- EPS next Q- Inst Own2.41% Short Float2.07% Perf Quarter-26.06%
Income-11.25M P/S0.33 EPS this Y- Inst Trans27.16% Short Ratio0.95 Perf Half Y-63.79%
Sales8.06M P/B1.57 EPS next Y- ROA-116.28% Short Interest0.04M Perf YTD-60.45%
Book/sh0.67 P/C3.36 EPS next 5Y- ROE-265.37% 52W High11.80 -91.10% Perf Year-80.63%
Cash/sh0.31 P/FCF- EPS past 3/5Y5.03% -4.07% ROIC-585.08% 52W Low0.86 22.81% Perf 3Y-97.78%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-5.86% 16.67% Gross Margin12.61% Volatility16.39% 9.21% Perf 5Y-
Dividend TTM- EV/Sales0.27 EPS Y/Y TTM49.76% Oper. Margin-141.04% ATR (14)0.10 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.31 Sales Y/Y TTM-13.05% Profit Margin-139.65% RSI (14)50.44 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.31 EPS Q/Q88.77% SMA206.18% Beta1.62 Target Price60.00
Payout- Debt/Eq0.18 Sales Q/Q-53.82% SMA50-5.30% Rel Volume2.97 Prev Close1.09
Employees24 LT Debt/Eq0.15 Earnings- SMA200-57.31% Avg Volume46.55K Price1.05
IPOJun 17, 2021 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume138,151 Change-3.67%
Jan-16-25 04:01PM
Dec-20-24 08:30AM
Dec-13-24 07:30AM
Dec-12-24 05:11PM
Nov-08-24 07:30AM
07:30AM Loading…
Nov-07-24 07:30AM
07:00AM
Oct-31-24 03:07PM
Oct-30-24 08:30AM
Sep-26-24 07:30AM
Sep-16-24 09:38AM
Sep-11-24 04:30PM
Aug-06-24 07:30AM
Jul-25-24 04:05PM
Jun-06-24 07:38AM
09:53AM Loading…
May-13-24 09:53AM
May-08-24 03:19AM
May-07-24 07:30AM
Apr-25-24 08:00AM
Mar-15-24 10:48AM
Mar-14-24 08:00AM
Mar-12-24 07:07PM
Mar-05-24 04:30PM
Jan-23-24 07:30AM
Jan-22-24 04:15PM
Jan-18-24 08:11AM
Dec-07-23 07:30AM
Nov-05-23 11:01AM
Nov-02-23 07:30AM
Oct-26-23 07:30AM
07:30AM Loading…
Oct-23-23 07:30AM
Sep-28-23 07:30AM
Sep-16-23 01:01AM
Sep-13-23 07:30AM
Sep-07-23 02:07PM
Sep-06-23 04:05PM
Aug-30-23 07:30AM
Aug-16-23 07:30AM
Aug-09-23 07:30AM
Aug-07-23 06:02AM
Aug-02-23 07:00AM
Jul-25-23 07:30AM
Jul-06-23 07:30AM
May-23-23 07:30AM
May-04-23 07:00AM
Apr-24-23 07:30AM
Apr-20-23 07:00AM
Apr-18-23 06:26AM
Mar-17-23 04:56AM
Mar-14-23 10:21PM
07:00AM
Mar-02-23 07:00AM
Feb-28-23 04:02PM
Feb-08-23 07:30AM
Jan-24-23 11:00AM
07:30AM
Jan-23-23 07:30AM
Jan-19-23 07:30AM
Jan-10-23 01:11PM
Dec-05-22 07:30AM
Nov-08-22 07:00AM
Oct-27-22 08:43AM
07:30AM
Oct-25-22 07:30AM
Oct-18-22 07:30AM
Oct-04-22 07:30AM
Sep-29-22 05:25AM
Sep-22-22 04:15PM
Aug-31-22 07:30AM
Aug-07-22 08:17AM
Aug-04-22 07:00AM
Jul-21-22 07:30AM
Jul-07-22 11:03AM
07:30AM
Jun-08-22 08:49AM
07:30AM
May-19-22 07:30AM
May-16-22 07:30AM
May-10-22 07:00AM
May-02-22 07:30AM
Apr-26-22 07:30AM
Apr-13-22 07:30AM
Mar-15-22 07:30AM
Mar-08-22 07:30AM
Feb-24-22 06:44AM
Feb-17-22 07:39AM
Feb-10-22 07:30AM
Feb-03-22 07:30AM
Jan-13-22 08:00AM
Jan-04-22 01:46PM
12:39PM
08:00AM
Dec-16-21 08:00AM
Dec-02-21 07:00AM
Dec-01-21 09:24PM
Nov-29-21 12:03AM
Nov-27-21 07:47AM
Nov-22-21 11:23AM
08:00AM
04:55AM
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.